Brinker Capital Investments, LLC Castle Biosciences Inc Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 32,824 shares of CSTL stock, worth $914,476. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,824
Previous 36,460
9.97%
Holding current value
$914,476
Previous $951,000
18.82%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CSTL
# of Institutions
171Shares Held
25.5MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$84.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$64.9 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$43.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.5MShares$41.7 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$33.9 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $733M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...